MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    The First of Its Kind Genetics Cohort: the Black and African American Connections to Parkinson’s Disease (BLAAC PD) Study

    N. Louie, J. Solle, S. Bandrés-Ciga (New York, USA)

    Objective: Recruit and characterize a Black and African American (BAA) cohort to better understand Parkinson’s disease (PD). Background: A significant gap exists in our understanding…
  • 2024 International Congress

    Genetic Modifiers of Age at Onset for Parkinson’s Disease in Chinese Population

    H. Pan, L. Liu, J. Guo, B. Tang, Y. Zhao (Changsha, China)

    Objective: This study aimed to identify novel genetic modifiers of age at onset (AAO) for Parkinson’s disease (PD) including common variants and rare variants using…
  • 2024 International Congress

    Parkinson’s Disease Risk Genotypes at the GPNMB Locus Associate with Extent of Post-mortem Lewy Pathology

    E. Brody, E. Suh, V. van Deerlin, J. Trojanowski, E. Lee, A. Chen-Plotkin (PHILADELPHIA, USA)

    Objective: To determine whether Parkinson’s disease (PD) risk genotypes at the GPNMB locus associate with distribution of Lewy pathology in brain samples from a spectrum…
  • 2024 International Congress

    Association of Impulse Control Disorder with GRIN2B Gene Polymorphisims in Parkinson Disease

    G. Memari, E. Erzurumluoglu, N. Durmaz Celik, S. özkan, S. Artan (Eskisehir, Turkey)

    Objective: The aim of this study was to investigate the effect of GRIN2B gene rs1806201 and rs7301328 polymorphisms on the development of Impulse Control Disorder…
  • 2024 International Congress

    Association of Liver Fibrosis with Motor Deficits in Parkinson’s Disease

    A. Zolin, H. Ooi, H. Sarva (New York, USA)

    Objective: To determine the impact of liver fibrosis on motor symptoms in Parkinson’s disease Background: Parkinson’s disease motor symptoms can vary with systemic illnesses [1,2].…
  • 2024 International Congress

    Maintaining Isometric Contraction in Parkinson’s Disease: Effect of PD-Medication on EMG Amplitude

    B. Afsharipour, F. Roy, M. Schindle, F. Ba, M. Gorassini, T. Sankar (Edmonton, Canada)

    Objective: To quantify muscle activity changes in PD with dopaminergic medication. Background: Parkinson's disease (PD) is characterized by motor symptoms that improve with dopaminergic medication.…
  • 2024 International Congress

    Assessing the Predictive Accuracy of Baseline Neuropsychiatric and Axial Motor Features for Freezing of Gait in Parkinson’s Disease at 5-year Follow up: The PPMI Cohort

    J. Li, R. Rajmohan, J. Ruiz Tejeda, N. Phielipp (Irvine, USA)

    Objective: To determine if neuropsychiatric and axial motor symptoms at baseline would be predictive of freezing of gait (FoG) at 5-year follow up in participants…
  • 2024 International Congress

    Study of Cytokine profile in a Tunisian Parkinson’s Disease cohort

    O. Ben Othman, S. Frikha, S. Fezai, A. Achouri, M. Ben Mahmoud, H. Jamoussi, S. Fray, M. Fredj, N. Ben Ali (Tunis, Tunisia)

    Objective: We aim to study the relationship between clinical features in patients with Parkinson’s disease (PD)  and their IL-6 and IL-1β serum levels. Background: According…
  • 2024 International Congress

    Decline in functionality according to WHODAS 2.0 associated with disease progression in people with Parkinson’s disease

    N. Pereira, K. Nóbrega, I. Nascimento, L. Matos, L. Aranha, C. de Paula, C. Santana, R. Bocicovar, G. Campos, F. Fidelis, G. Dos Santos, I. Barone, V. Ponciano, M. Piemonte (São Paulo, Brazil)

    Objective: To investigate the decline in functionality according to WHODAS-2.0 from early to intermediate stages of PD. Background: Parkinson's disease (PD) is an incurable and…
  • 2024 International Congress

    Beyond Memory:A Brain Health Awareness Kit for Spanish-speaking Communities

    M. Alosilla, C. Alvarez-Pizzillo, S. Avion-Martinez, J. Cabassa, B. Cavedoni Urbano, L. Crawford, M. de Leon, E. Fernandez Toledo, G. Moya-Gale, S. Perez, N. Walker-Pizarro, H. Shah (Hialeah, USA)

    Objective: To develop an interactive workshop in Spanish that provides basic information about brain health and its importance so that community members can identify risk…
  • « Previous Page
  • 1
  • …
  • 178
  • 179
  • 180
  • 181
  • 182
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley